+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Human Papillomavirus"

Throat Cancer Global Market Report 2025 - Product Thumbnail Image

Throat Cancer Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Head and Neck Squamous Cell Carcinoma Market Report 2025 - Product Thumbnail Image

Head and Neck Squamous Cell Carcinoma Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Head and Neck Cancer (HNC) Market Report 2025 - Product Thumbnail Image

Head and Neck Cancer (HNC) Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Vulvar Cancer Global Market Report 2025 - Product Thumbnail Image

Vulvar Cancer Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
From
Cancer Registry Software - Global Strategic Business Report - Product Thumbnail Image

Cancer Registry Software - Global Strategic Business Report

  • Report
  • August 2025
  • 217 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

The Human Papillomavirus (HPV) is a virus that can cause a variety of cancers, including cervical, anal, and oropharyngeal cancers. In the oncology market, HPV-related treatments are used to treat these cancers, as well as to prevent them from occurring in the first place. HPV vaccines are used to prevent infection with the virus, while treatments such as chemotherapy and radiation therapy are used to treat HPV-related cancers. Additionally, targeted therapies such as immunotherapy and monoclonal antibodies are used to treat HPV-related cancers. In the HPV market, there are a number of companies that are involved in the development and manufacture of treatments and vaccines. These include Merck, GlaxoSmithKline, Sanofi, Pfizer, and AstraZeneca. Additionally, there are a number of smaller companies that are involved in the development of treatments and vaccines for HPV-related cancers. Show Less Read more